<DOC>
	<DOCNO>NCT01586975</DOCNO>
	<brief_summary>The purpose study determine PFA result correlate ischemic event outcomes well bleed complication . Hypothesis antiplatelet agent efficacious administer dose-adjusted manner use PFA result guide .</brief_summary>
	<brief_title>Aspirin Resistance Stroke Risk : Platelet Function Analysis Patients With Ischemic Events</brief_title>
	<detailed_description>Atherothrombotic disease lead killer adult throughout world . The current mainstay prevention ischemic vascular event use aspirin Antiplatelet agent use routinely primary secondary prevention vascular event patient prior history stroke , TIA , high risk development cerebrovascular disease . Numberous individual study meta-analyses show essentially oral antiplatelet agent limited efficacy , relative risk reduction range 20-35 % . The purpose study perform serial platelet function assay ( PFAs ) patient cerebrovascular disease take antiplatelet agent perform pilot study determine feasibility administer ASA dose adjust medication use PFA . The long term goal study determine whether antiplatelet therapy efficacious and/or safer administer dose-adjusted manner .</detailed_description>
	<mesh_term>Stroke</mesh_term>
	<mesh_term>Infarction</mesh_term>
	<mesh_term>Myocardial Infarction</mesh_term>
	<mesh_term>Aspirin</mesh_term>
	<mesh_term>Ticlopidine</mesh_term>
	<mesh_term>Clopidogrel</mesh_term>
	<criteria>Patient must take Aspirin Plavix Patient must stroke , TIA cerebrovascular disease</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2015</verification_date>
</DOC>